Today

Agents

Chat

Arena

Discover

More

App

Sight Sciences wins FDA 510(k) clearance for OMNI Ultra glaucoma system - SGHT News | Rallies

Sight Sciences wins FDA 510(k) clearance for OMNI Ultra glaucoma system

SGHT•2026-08-04

FDA clearance for OMNI Ultra

Sight Sciences won FDA 510(k) clearance for OMNI Ultra, a minimally invasive glaucoma surgery system for canaloplasty followed by trabeculotomy in adult POAG.
U.S. commercial launch targeted for Q4 2026.

Related News

DaVita flags lower revenue per treatment, reaffirms annual forecast

DVA•2026-08-04

Light & Wonder Q2 revenue rises on gaming operations

LNW•2026-08-04

Sunrun prices USD 267 million residential solar asset-backed securitization notes

2026-08-04

Gilead forecasts FY26 Yeztugo revenue at about $1 billion

GILD•2026-08-04

LATAM Q2 FY26 net income rises to US$125 million; revenue increases 28% to US$4.2 billion

LTM•2026-08-04